Illumina's banner

Illumina

@illumina • 95,816 subscribers

Dedicated to advancing human health by unlocking the power of the #genome. 🧬

Shorts

1 billion cells. One atlas. Today, Illumina introduces the Billion Cell Atlas, creating the most comprehensive map of human disease biology — and unlocking unparalleled speed and scale in AI for drug discovery. The Atlas will help researchers, including founding participants AstraZeneca, Merck, and Eli Lilly and Company study the effect of switching on and off all 20,000 genes in cells linked to diseases that have been historically difficult to decode. Learn how the Atlas will elucidate the biological pathways behind some of the world’s most devastating diseases: #JPM2026

1 billion cells. One atlas. Today, Illumina introduces the Billion Cell Atlas, creating the most comprehensive map of human disease biology — and unlocking unparalleled speed and scale in AI for drug discovery. The Atlas will help researchers, including founding participants AstraZeneca, Merck, and Eli Lilly and Company study the effect of switching on and off all 20,000 genes in cells linked to diseases that have been historically difficult to decode. Learn how the Atlas will elucidate the biological pathways behind some of the world’s most devastating diseases: #JPM2026

34,201 views

The future of drug discovery is here. Formation Bio is joining our Billion Cell Atlas program to help redefine what’s possible in AI-driven drug development, advancing the next generation of therapeutics. By addressing key bottlenecks across the drug discovery continuum, the Atlas can help accelerate the journey from biological insights to approved drugs — bringing greater precision to how we understand what works, why it works, and which patient populations are most likely to benefit. Together, we’re helping bring more precision medicines to life and reimagine what’s possible in biology. Discover the next era:

The future of drug discovery is here. Formation Bio is joining our Billion Cell Atlas program to help redefine what’s possible in AI-driven drug development, advancing the next generation of therapeutics. By addressing key bottlenecks across the drug discovery continuum, the Atlas can help accelerate the journey from biological insights to approved drugs — bringing greater precision to how we understand what works, why it works, and which patient populations are most likely to benefit. Together, we’re helping bring more precision medicines to life and reimagine what’s possible in biology. Discover the next era:

10,242 views

The next big thing in sequencing is coming. And it’s small. Learn more at our virtual event on October 9 at 9 a.m. PT:

The next big thing in sequencing is coming. And it’s small. Learn more at our virtual event on October 9 at 9 a.m. PT:

35,406 views

Videos

Anya Rossi

sweetdream.ai

SweetDream.ai•Sponsored•Livecam

Watch Anya Live

Anya is streaming live right now! Join her private show and enjoy exclusive content.

Exclusive private shows

1.2k viewers online

Private Show

Join now for exclusive access

Free preview available • Premium content

Meet the MiSeq i100 Series – the new standard in sequencing simplicity. With 3-step setup, onboard DRAGEN analysis, and same-day results, what will you discover next?

Meet the MiSeq i100 Series – the new standard in sequencing simplicity. With 3-step setup, onboard DRAGEN analysis, and same-day results, what will you discover next?

28,350 views • 1 year ago

A NextSeq 2000 on a boat? You read that right—the OceanOmics team at the Minderoo Foundation Foundation is sequencing eDNA at sea, off the coast of Western Australia, to conserve marine biodiversity and protect our oceans. More on our partnership: #EarthDay

A NextSeq 2000 on a boat? You read that right—the OceanOmics team at the Minderoo Foundation Foundation is sequencing eDNA at sea, off the coast of Western Australia, to conserve marine biodiversity and protect our oceans. More on our partnership: #EarthDay

17,909 views • 3 years ago

Introducing the new P4 flow cell. Offering 1.8B reads and 50% more output, the NextSeq 2000 is pushing the boundaries for benchtop sequencers. Make your ambitious research a reality:

Introducing the new P4 flow cell. Offering 1.8B reads and 50% more output, the NextSeq 2000 is pushing the boundaries for benchtop sequencers. Make your ambitious research a reality:

12,536 views • 2 years ago

No more content to load